Joseph Robert has made an “outstanding response” to treatment for brain tumours and is back working full time at his firm, JE Robert Companies.
In February, growths were discovered on Robert’s brain, with the founder undergoing immediate treatment.
In a statement today, Robert’s clinical team said the founder had made an “absolutely outstanding response to treatment thus far,” with Dr. Howard Fine, chief of the Neuro Oncology branch at the National Cancer Institute Center for Cancer Research, adding: “We are extremely pleased with his progress to date.”
The statement was issued by JER Investors Trust – JER’s real estate investment trust. JE Robert Companies also runs the private equity real estate firm, JER Partners.
The growths discovered in February have now disappeared although Robert will continue to receive treatment, according to the statement. “[Robert] is actively managing the firm's global activities. He is engaged with his staff, colleagues and investors,” the statement said.
A JER spokesman previously confirmed to PERE that Robert underwent chemotherapy and radiation treatment.
JE Robert Companies has had a turbulent few months, with departures of global chief operating officer Michael Pralle and European head Malcolm le May in the space of a few months. The firm has also seen JER Investors Trust delisted from the New York Stock Exchange.